{"nct_id":"NCT05128942","title":"A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children with CAH","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2021-12-10","start_date_type":"ACTUAL","primary_completion_date":"2025-01-31","primary_completion_date_type":"ACTUAL","completion_date":"2025-01-31","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SPRB"]}